Compare Pfizer Inc (PFE) vs SK Hynix (SKHY) Price & Performance

Pfizer IncTrade

SK HynixTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs SK Hynix — how do they compare? Pfizer Inc trades at $28.24 (market cap $158.56B), while SK Hynix trades at $169.61 (market cap $891.31B). The key difference: SK Hynix is far larger — about 5.6× Pfizer Inc's market cap, and Pfizer Inc pays the higher dividend (6.18%). Which is the better fit depends on your goals — on Pluang, investors hold Pfizer Inc for 158 Days and SK Hynix for 10 Days on average.

	PFE	SKHY
Market Cap	$158.56B	$891.31B
Volume	44,138,282	22,268,296
Sector	Health	Technology
52-Week High	$29.02	$198.63
52-Week Low	$23.67	$126.79
Typical Hold Time	158 Days	10 Days
Enterprise Value	$210.06B	$841.45B
Dividend Yield	6.18%	0.06%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.

The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.

SK Hynix

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PFE

11% Buy89% Sell

Avg holding period · 158 Days

SKHY

79% Buy21% Sell

Avg holding period · 10 Days

Top news

Latest headlines on both assets

PFE

Pfizer's dividend yield tops 6%, signaling caution amid cash flow pressures and patent challenges.24/7 Wall Street · 8 hours agoNeutral Moderna jumps 5% on NASDAQ 100 inclusion, outpacing Pfizer and BioNTech amid oncology pipeline optimism.24/7 Wall Street · 10 hours agoBullish Cantor Fitzgerald raises price targets on Eli Lilly, AbbVie, Merck, and Pfizer amid mixed growth outlooks.24/7 Wall Street · 14 hours agoBullish View details →

SKHY

SK hynix upgraded to Buy on strong 5-year demand visibility and undervaluation amid AI-driven growth.Seeking Alpha · 1 day agoBullish SK Hynix shares drop 4% on earnings caution despite strong AI demand and tight memory supply.24/7 Wall Street · 3 days agoBearish View details →

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

About SK Hynix

SK hynix is a South Korean semiconductor company that manufactures memory products, including DRAM and NAND flash. Its high-bandwidth memory (HBM) products are designed for high-performance computing and AI applications.